TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 173 filers reported holding TRAVERE THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 1,776,728 | $14,604,704 | 4.15% |
| Exome Asset Management LLC | 443,379 | $3,644,576 | 3.17% |
| Deep Track Capital, LP | 7,370,000 | $60,581,400 | 1.81% |
| Talbot Financial, LLC | 63,546 | $12,921,444 | 1.67% |
| Kynam Capital Management, LP | 2,021,659 | $16,618,037 | 1.28% |
| Rock Springs Capital Management LP | 4,482,265 | $36,844,218 | 1.11% |
| Parkman Healthcare Partners LLC | 969,892 | $7,972,512 | 1.07% |
| Birchview Capital, LP | 122,000 | $1,002,840 | 0.93% |
| Knott David M Jr | 265,966 | $2,186 | 0.87% |
| ARMISTICE CAPITAL, LLC | 7,500,000 | $61,650,000 | 0.78% |
| HighVista Strategies LLC | 219,416 | $1,803,600 | 0.66% |
| Eversept Partners, LP | 1,091,165 | $8,969,376 | 0.61% |
| EMERALD ADVISERS, LLC | 1,637,146 | $13,457,340 | 0.56% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 941,265 | $7,737,198 | 0.40% |
| PDT Partners, LLC | 238,783 | $1,962,796 | 0.19% |
| Virtus ETF Advisers LLC | 45,490 | $373,928 | 0.18% |
| Pennant Investors, LP | 55,800 | $458,676 | 0.12% |
| Palo Alto Investors LP | 110,719 | $910,110 | 0.10% |
| Woodline Partners LP | 1,276,878 | $10,495,937 | 0.10% |
| Crestline Management, LP | 103,353 | $849,562 | 0.07% |
External links
This page lists TRAVERE THERAPEUTICS INC's shareholders in Q2 2024. To view TRAVERE THERAPEUTICS INC's shareholder history, click here.